LGVN - Longeveron Inc Stock Price & Dividend Safety Sector: Healthcare | Exchange: NASDAQ Capital Market Current Price & Safety Score Price: 1.73 USD StockBonds Safety Grade: F Altman Z-Score (Bankruptcy Risk): -16.76 StockBond Score: -3.89 Company Description Longeveron Inc is a biotechnology company currently in the clinical development stage dedicated to pioneering cellbased therapies These treatments are designed to address both agerelated conditions and various critical lifethreatening illnesses The companys primary investigational product is LOMECELB a sophisticated cellular therapy This product is created from medicinal signaling cells that are cultivated and expanded after being harvested from the bone marrow of healthy young adult donors Longeveron is actively conducting Phase 1 and Phase 2 clinical trials to evaluate LOMECELBs potential across a diverse range of indications These include agerelated frailty Alzheimers disease metabolic syndrome acute respiratory distress syndrome ARDS and hypoplastic left heart syndrome HLHS Established in 2014 Longeveron Inc operates from its headquarters in Miami Florida